Extended duration letermovir in allogeneic hematopoietic stem cell transplant
CONCLUSION: The results of this study suggest that extended duration letermovir prophylaxis may be associated with less CMV reactivation compared to the standard duration of prophylaxis.PMID:37770000 | DOI:10.1016/j.trim.2023.101936
Source: Transplant Immunology - Category: Transplant Surgery Authors: Breanna Hinman James Cox Godsfavour Umoru Rammurti Kamble Will Musick Source Type: research
More News: Allergy & Immunology | Cytomegalovirus | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants